Simulations Plus Announces Leadership Changes and Business Unit Restructuring

Simulations Plus, Inc.

Steven Chang promoted to President, Quantitative Systems Pharmacology, effective August 30, 2024.
Jenna Rouse named President of newly formed Adaptive Learning & Insights business unit.
Murry Alper named President of newly formed Medical Communications business unit.
Sandra Suarez-Sharp transitions to President, Regulatory Strategies Center of Excellence.
Brett Howell (former President, QSP) and Michael Raymer depart after assisting transition.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Brett Howell

President, Quantitative Systems Pharmacology

SLP · Simulations Plus, Inc.

Effective: 2024-08-30
Filed: August 23, 2024, 7:59 PM ET

Effective August 30, 2024, Dr. Brett Howell, Ph.D., has departed the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Brett Howell departed as President, Quantitative Systems Pharmacology at Simulations Plus, Inc..

Action: departed
Role: President, Quantitative Systems Pharmacology

Exact text from the filing

Effective August 30, 2024, Dr. Brett Howell, Ph.D., has departed the Company.

View on SEC.gov

Simulations Plus, Inc. filing history →

Source: SEC EDGAR

accession 0001023459-24-000105

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.